Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 17 matching records.
17 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Research progress of exosomes used in the Alzheimer's disease treatment
Narrative Review on Neuroinflammation, published in Discov Nano (2025) — summary generated from the PubMed abstract.
- 2025
Discov Nano1 citations - Level BClinical TrialPubMed
Therapeutic and Diagnostic Roles of MSC-Derived Exosomes in Alzheimer's Disease.
Clinical Trial on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Brain Behav (2025) — summary generated from the PubMed abstract.
- 2025
Brain Behav - Level DLaboratory StudyEurope PMC
Key developments and hotspots of exosomes in Alzheimer's disease: a bibliometric study spanning 2003 to 2023
Laboratory Study on Neuroinflammation, published in Front Aging Neurosci (2024) — summary generated from the PubMed abstract.
- 2024
Front Aging Neurosci3 citations - Level DNarrative ReviewEurope PMC
Unveiling the Complex Role of Exosomes in Alzheimer's Disease
Narrative Review on Neuroinflammation, published in J Inflamm Res (2024) — summary generated from the PubMed abstract.
- 2024
J Inflamm Res21 citations - Level ASystematic ReviewPubMed
Insights on the Characteristics and Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes for Mitigation of Alzheimer's Disease's Pathogenicity: A Systematic Review.
Systematic Review on Neuroinflammation, Chronic Inflammation, published in Cell Biochem Biophys (2024) — summary generated from the PubMed abstract.
- 2024
Cell Biochem Biophys1 citations - Level DAnimal StudyPubMed
Molecular intersections of traumatic brain injury and Alzheimer's disease: the role of ADMSC-derived exosomes and hub genes in microglial polarization.
Animal Study on Neuroinflammation, published in Metab Brain Dis (2024) — summary generated from the PubMed abstract.
- 2024
Metab Brain Dis - Level DNarrative ReviewEurope PMC
The emerging double-edged sword role of exosomes in Alzheimer's disease
Narrative Review on Neuroinflammation, published in Front Aging Neurosci (2023) — summary generated from the PubMed abstract.
- 2023
Front Aging Neurosci33 citations - Level DNarrative ReviewEurope PMC
Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease
Narrative Review on Neuroinflammation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci19 citations - Level BClinical TrialPubMed
Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial.
Clinical Trial on Neuroinflammation, published in Gen Psychiatr (2023) — summary generated from the PubMed abstract.
- 2023
Gen Psychiatr - Level DAnimal StudyPubMed
Hypoxic pretreatment of adipose-derived stem cell exosomes improved cognition by delivery of circ-Epc1 and shifting microglial M1/M2 polarization in an Alzheimer's disease mice model.
Animal Study on Neuroinflammation, published in Aging (Albany NY) (2022) — summary generated from the PubMed abstract.
- 2022
Aging (Albany NY)52 citations - Level DAnimal StudyPubMed
Neuroprotective effects of coenzyme Q10-loaded exosomes obtained from adipose-derived stem cells in a rat model of Alzheimer's disease.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Biomed Pharmacother (2022) — summary generated from the PubMed abstract.
- 2022
Biomed Pharmacother73 citations - Level DNarrative ReviewEurope PMC
The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer's Disease
Narrative Review on Neuroinflammation, published in Front Aging Neurosci (2022) — summary generated from the PubMed abstract.
- 2022
Front Aging Neurosci31 citations - Level DAnimal StudyPubMed
Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer's disease.
Animal Study on Neuroinflammation, Chronic Inflammation, published in J Drug Target (2021) — summary generated from the PubMed abstract.
- 2021
J Drug Target - Level DNarrative ReviewEurope PMC
Exosomes in Alzheimer's Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics
Narrative Review on Neuroinflammation, published in Int J Mol Sci (2021) — summary generated from the PubMed abstract.
- 2021
Int J Mol Sci60 citations - Level DNarrative ReviewEurope PMC
Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer's Disease
Narrative Review on Neuroinflammation, published in Clin Interv Aging (2020) — summary generated from the PubMed abstract.
- 2020
Clin Interv Aging62 citations - Level DNarrative ReviewEurope PMC
Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease
Narrative Review on Neuroinflammation, published in Med Sci Monit (2019) — summary generated from the PubMed abstract.
- 2019
Med Sci Monit100 citations - Level DNarrative ReviewPubMed
Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer's Disease.
Narrative Review on Neuroinflammation, Chronic Inflammation, published in Front Cell Neurosci (2018) — summary generated from the PubMed abstract.
- 2018
Front Cell Neurosci
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406